Metraipolis › archive › dc_ec93bdba2bb4

AXL-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer — Europe PMC PMID:42279342

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279342
DOI
10.3390/cancers18111759
License (as archived)
solo-consultazione
Archived
2026-11-01T03:29:46.086Z
SHA-256 of the archived text
1348eff90684fa559e9d08642ab29aca58d68d8cf018ddcf09ec8843a6e0b414
Stable URL of this page
https://metraipolis.com/documento/dc_ec93bdba2bb4

How to cite

AXL-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer — Europe PMC PMID:42279342 — Europe PMC (en), https://europepmc.org/article/MED/42279342 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec93bdba2bb4 (Metraipolis archive dc_ec93bdba2bb4, sha256 1348eff90684fa559e9d08642ab29aca58d68d8cf018ddcf09ec8843a6e0b414)
BibTeX
@misc{dcec93bdba2bb4,
  title = {AXL-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer — Europe PMC PMID:42279342},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279342},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec93bdba2bb4; sha256 1348eff90684fa559e9d08642ab29aca58d68d8cf018ddcf09ec8843a6e0b414},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279342. Agents can read the archived copy with the MCP tool read_document.